BofA Securities analyst Alec Stranahan raised the price target on Krystal Biotech (NASDAQ: KRYS) to $396.00 (from $364.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE